A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
about
Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD.Bronchodilator reversibility in patients with COPD revisited: short-term reproducibilityChronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management.Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study.Next generation beta adrenoreceptor agonists for the treatment of asthma.
P2860
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A dose-ranging study of the br ...... a Phase II, randomized study.
@ast
A dose-ranging study of the br ...... a Phase II, randomized study.
@en
type
label
A dose-ranging study of the br ...... a Phase II, randomized study.
@ast
A dose-ranging study of the br ...... a Phase II, randomized study.
@en
prefLabel
A dose-ranging study of the br ...... a Phase II, randomized study.
@ast
A dose-ranging study of the br ...... a Phase II, randomized study.
@en
P2093
P2860
P356
P1476
A dose-ranging study of the br ...... a Phase II, randomized study.
@en
P2093
Anna Ribera
Beatriz Seoane
Carol Astbury
Dave Singh
Eric Massana
Gonzalo de Miquel
Helena Pujol
Sandrine Ruiz
P2860
P2888
P356
10.1186/1471-2466-14-176
P577
2014-11-14T00:00:00Z
P5875
P6179
1033717193